A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials

Abstract Personalized cancer therapy seeks to tailor treatment to an individual patient’s biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joshua S. Niedzielski, Jinzhong Yang, Francesco Stingo, Zhongxing Liao, Daniel Gomez, Radhe Mohan, Mary Martel, Tina Briere, Laurence Court
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/966915397e484ccb974449090e63c828
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:966915397e484ccb974449090e63c828
record_format dspace
spelling oai:doaj.org-article:966915397e484ccb974449090e63c8282021-12-02T11:52:15ZA Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials10.1038/s41598-017-05003-x2045-2322https://doaj.org/article/966915397e484ccb974449090e63c8282017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05003-xhttps://doaj.org/toc/2045-2322Abstract Personalized cancer therapy seeks to tailor treatment to an individual patient’s biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal toxicity, esophageal expansion, as a method to quantify radiosensitivity in 134 non-small-cell lung cancer patients, by using K-Means clustering to group patients based on esophageal radiosensitivity. Patients within the cluster of higher response and lower dose were labelled as radiosensitive. This information was used as a variable in toxicity prediction modelling (lasso logistic regression). The resultant model performance was quantified and compared to toxicity prediction modelling without utilizing radiosensitivity information. The esophageal expansion-response was highly variable between patients, even for similar radiation doses. K-Means clustering was able to identify three patient subgroups of radiosensitivity: radiosensitive, radio-normal, and radioresistant groups. Inclusion of the radiosensitive variable improved lasso logistic regression models compared to model performance without radiosensitivity information. Esophageal radiosensitivity can be quantified using esophageal expansion and K-Means clustering to improve toxicity prediction modelling. Finally, this methodology may be applied in clinical trials to validate pre-treatment biomarkers of esophageal toxicity.Joshua S. NiedzielskiJinzhong YangFrancesco StingoZhongxing LiaoDaniel GomezRadhe MohanMary MartelTina BriereLaurence CourtNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Joshua S. Niedzielski
Jinzhong Yang
Francesco Stingo
Zhongxing Liao
Daniel Gomez
Radhe Mohan
Mary Martel
Tina Briere
Laurence Court
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
description Abstract Personalized cancer therapy seeks to tailor treatment to an individual patient’s biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal toxicity, esophageal expansion, as a method to quantify radiosensitivity in 134 non-small-cell lung cancer patients, by using K-Means clustering to group patients based on esophageal radiosensitivity. Patients within the cluster of higher response and lower dose were labelled as radiosensitive. This information was used as a variable in toxicity prediction modelling (lasso logistic regression). The resultant model performance was quantified and compared to toxicity prediction modelling without utilizing radiosensitivity information. The esophageal expansion-response was highly variable between patients, even for similar radiation doses. K-Means clustering was able to identify three patient subgroups of radiosensitivity: radiosensitive, radio-normal, and radioresistant groups. Inclusion of the radiosensitive variable improved lasso logistic regression models compared to model performance without radiosensitivity information. Esophageal radiosensitivity can be quantified using esophageal expansion and K-Means clustering to improve toxicity prediction modelling. Finally, this methodology may be applied in clinical trials to validate pre-treatment biomarkers of esophageal toxicity.
format article
author Joshua S. Niedzielski
Jinzhong Yang
Francesco Stingo
Zhongxing Liao
Daniel Gomez
Radhe Mohan
Mary Martel
Tina Briere
Laurence Court
author_facet Joshua S. Niedzielski
Jinzhong Yang
Francesco Stingo
Zhongxing Liao
Daniel Gomez
Radhe Mohan
Mary Martel
Tina Briere
Laurence Court
author_sort Joshua S. Niedzielski
title A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
title_short A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
title_full A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
title_fullStr A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
title_full_unstemmed A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
title_sort novel methodology using ct imaging biomarkers to quantify radiation sensitivity in the esophagus with application to clinical trials
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/966915397e484ccb974449090e63c828
work_keys_str_mv AT joshuasniedzielski anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT jinzhongyang anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT francescostingo anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT zhongxingliao anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT danielgomez anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT radhemohan anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT marymartel anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT tinabriere anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT laurencecourt anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT joshuasniedzielski novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT jinzhongyang novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT francescostingo novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT zhongxingliao novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT danielgomez novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT radhemohan novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT marymartel novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT tinabriere novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
AT laurencecourt novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials
_version_ 1718395117949157376